Navigation Links
Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
Date:2/14/2008

QUEBEC CITY, Feb. 14 /PRNewswire-FirstCall/ - Atrium Innovations Inc. (TSX: ATB) will hold its quarterly conference call and webcast at 1:30 p.m. Eastern time on February 29, 2008. The call will follow the press release of Atrium's 2007 fourth quarter and full year results issued earlier that day. Participants may access the call by using the following numbers: 416-644-3420, 514-807-8791 or 800-731-5774 or via the Company's website at http://www.atrium-innov.com in the "Investors" section.

A replay of the webcast will also be available on our website http://www.atrium-innov.com in the "Investors" section for a period of 30 days.

About Atrium

Atrium Innovations Inc. is a recognized leading developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries. The Company focuses primarily on growing segments of the health and personal care markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through its highly specialized sales and marketing network in more than 50 countries, primarily in North America, Europe and Asia. Atrium has over 600 employees and operates four manufacturing facilities. Additional information about Atrium is available on its Web site at http://www.atrium-innov.com.

Cautionary Note and Forward-Looking Statements

This press release contains certain forward-looking statements with respect to the Company. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by these forward-looking statements. The Co
'/>"/>

SOURCE Atrium Innovations Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Atrium Innovations Announces Management Changes
4. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
5. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
6. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
7. Ten Extraordinary Innovations Line Up For US $100,000 Saatchi & Saatchi Award For World Changing Ideas
8. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
9. Inverness Medical Innovations Acquires ParadigmHealth
10. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
11. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... EpiVax, Inc. today announced a collaborative ...: RHHBY) aimed at evaluating EpiVax’s propri...y reduce detrimental immune responses to certain d...ion, the EpiVax Tregitope technology will be evalu...tein therapeutics. , (Voc...
(Date:12/1/2009)...OLIS and NORTH VANCOUVER, British Columbia, Dec. 1... wholly owned subsidiary of The Dow Chemical Compa...today announced the signing of a research and comm...vides Dow AgroSciences with access to Agrisoma,s p...on an exclusive basis in major food crops, and on ...
(Date:12/1/2009)... DNA Genotek, a leading provider of products f...hat Tepnel Pharmaceutical Services will offer Orag... nucleic acid extraction and genotyping service. ...ber 1, 2009 -- DNA Genotek , a leading provider o... announced that Tepnel Pharmaceutical Services w...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of the hi... Technologies, a business development and intellec...erging nanotechnology space. The company also pla...a nanotechnology incubator. , ...hael R. Drapp , a 34-year veteran of the high-tech...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
... article, we looked at the leading pharmaceutical ...ical market, which for the first time surpassed $...art of equation, as another significant market is ...ve numbers on the size of the total medical device...d $200 billion in annual revenue in 2005, as the t...
.... - SecurePipe , an Illinois-based provider of n...ork operations center in Madison and more than 50 ...t of two new senior executives to its core managem...sales for the Atlanta-based Internet security serv...the new senior vice president of sales and busines...
... ,90s, a constant parade of start-ups came through...monetizing eyeballs" and revenue sharing to genera...We all know how that story ended: companies - eBay...hat presented a strong value proposition to consum...ther companies for their businesses, more or less,...
Other Biology Technology:Midwest retains dominant role in 2005 world medical device market 2Midwest retains dominant role in 2005 world medical device market 3Midwest retains dominant role in 2005 world medical device market 4Midwest retains dominant role in 2005 world medical device market 5Midwest retains dominant role in 2005 world medical device market 6Midwest retains dominant role in 2005 world medical device market 7SecurePipe appoints two senior execs 2Searching for revenue streams 2Searching for revenue streams 3
(Date:11/26/2009)...er 26, 2009) Whitehead researchers have developed...inpoint specific genes and proteins used by pathog... most human cell cultures genes are present in two...m the mother. Gene inactivation by mutation is the...vated, the second copy usually remains active and ...
(Date:11/26/2009)...ant Staphylococcus Aureus ) and other drug-resist...ature plasma prototype devices have been developed...idal cocktails. , Two prototype devices have bee...lthy skin (e.g. hands and feet) in hospitals and p...at; and another to shoot bacteria-killing agents i...
(Date:11/25/2009)...ced in the stomach, may be used to boost resistanc...ase, Yale School of Medicine researchers report in...al of Neuroscience . , Parkinson,s disease is ca...rea of the midbrain known as the substantia nigra,...duced production of dopamine in late-stage Parkins...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Emerson Ecologics Expands Their Team of Naturopathic Doctors 51718 1Emerson Ecologics Expands Their Team of Naturopathic Doctors 51718 2Vasogen Announces Second Quarter 2009 Results 13030 1Vasogen Announces Second Quarter 2009 Results 13030 2Vasogen Announces Second Quarter 2009 Results 13030 3Vasogen Announces Second Quarter 2009 Results 13030 4Vasogen Announces Second Quarter 2009 Results 13030 5Vasogen Announces Second Quarter 2009 Results 13030 6Vasogen Announces Second Quarter 2009 Results 13030 7Vasogen Announces Second Quarter 2009 Results 13030 8Vasogen Announces Second Quarter 2009 Results 13030 9Vasogen Announces Second Quarter 2009 Results 13030 10Educated Parkinsons Patients Move to Meds Sooner 51713 1Educated Parkinsons Patients Move to Meds Sooner 51713 2
...sh virus has been found for the first time in a va...d States by Cornell University researchers. , Acc...gram at Cornell,s College of Veterinary Medicine, ...ch causes fatal anemia and hemorrhaging in many fi... poses no threat to humans. , In May 2006, the ...
... at the University of California, San Diego and th...t time a web of inter-related responses that cells... being exposed to a powerful chemical mutagen. Th...Ideker describe in the May 19 issue of Science an ... by chemical damage to DNA. , "This research sheds...
...entists have linked a chemical that plays an essen...mage and male infertility, the 22nd annual confere...heard today (Monday). , Dr Iraj Amiri, embryology ...spital, Hamadan, Iran, said: "In recent years nitr...at plays an important role in regulating the biolo...
Other Biology News:Cornell researchers find serious fish virus in Northeast for first time 2Heal thyself: Systems biology model reveals how cells avoid becoming cancerous 2Heal thyself: Systems biology model reveals how cells avoid becoming cancerous 3Study links high levels of nitric oxide to infertility and sperm DNA damage 2
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-mSmac/DIABLO (CT) Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-Human ADAMTS16 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human acetyl-Histone H3 (Lys 4) Antibody, Unconjugated from Upstate
Biology Products: